We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Quintiles and Kaiser Permanente Announce Alliance to Accelerate Drug Development

News   May 21, 2010

 
Quintiles and Kaiser Permanente Announce Alliance to Accelerate Drug Development
 
 
 

RELATED ARTICLES

Even Short-term Vaping Causes Inflammation in Non-smokers, Says Pilot Study

News

Researchers report the first evidence of biological changes correlated with e-cigarette use in never-smokers.

READ MORE

New Centers Aim To Drive Green Chemistry Innovation

News

Monash University has received $8.6 million in Federal Government funding to establish dedicated research training centers that are set to drive the innovation of green chemistry in Australian manufacturing.

READ MORE

Fungus Chemistry May Mimic Opioids With Fewer Side Effects

News

The hunt for an opioid alternative has made a leap forward – a unique fungus may be able to mimic opioid suggesting it could be a safer less addictive drug, helping address the opioid epidemic of deaths by overdose.

READ MORE

 

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE